IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 66 filers reported holding IMMUNE DESIGN CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,487,000 | -23.0% | 270,334 | +6.1% | 0.00% | – |
| Q3 2016 | $1,931,000 | +3.1% | 254,772 | +11.0% | 0.00% | – |
| Q2 2016 | $1,873,000 | -37.6% | 229,546 | -0.6% | 0.00% | – |
| Q1 2016 | $3,002,000 | -36.7% | 230,886 | -2.3% | 0.00% | -100.0% |
| Q4 2015 | $4,746,000 | +84.4% | 236,368 | +12.0% | 0.00% | – |
| Q3 2015 | $2,574,000 | -24.7% | 210,962 | +27.4% | 0.00% | -100.0% |
| Q2 2015 | $3,419,000 | +118.7% | 165,567 | +123.6% | 0.00% | – |
| Q1 2015 | $1,563,000 | +6.3% | 74,061 | +55.0% | 0.00% | – |
| Q4 2014 | $1,470,000 | +71.5% | 47,766 | -1.6% | 0.00% | – |
| Q3 2014 | $857,000 | – | 48,530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,236,394 | $4,080,000 | 4.69% |
| Versant Venture Management, LLC | 2,208,210 | $7,287,093,000 | 2.33% |
| EcoR1 Capital, LLC | 4,437,600 | $14,422,000 | 1.45% |
| BVF INC/IL | 4,106,200 | $13,550,000 | 1.37% |
| Abingworth LLP | 352,300 | $1,145,000 | 0.71% |
| DAFNA Capital Management LLC | 328,500 | $1,084,000 | 0.53% |
| Bain Capital Public Equity Management, LLC | 1,680,987 | $5,547,000 | 0.40% |
| Telemetry Investments, L.L.C. | 248,800 | $821,000 | 0.31% |
| Stonepine Capital Management, LLC | 161,226 | $532,000 | 0.28% |
| Focused Wealth Management, Inc | 12,395 | $41,000 | 0.01% |